Medicine
Fosaprepitant 150 mg powder for injection
Fosaprepitant 150 mg powder for injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store at 2° to 8°C (36° to 46°F). For storage of reconstituted drug solution…
Key facts
- Active ingredient (INN)
- Fosaprepitant
- Brand
- Sold under the generic name
- Strength
- 150 mg
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial, 1 injection
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaActavis Pharma
- Origin register
- US FDA, United States
- Storage
- Store at 2° to 8°C (36° to 46°F). For storage of reconstituted drug solution see Dosage and Administration 2.2.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AD12 Fosaprepitant
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 September 2019
- Identifiers
- RxCUI 1731077DailyMed set ID 9dbd4c29-d894-4839-9b22-a2f65c8c8ad1, 557a48d5-0e1f-f3d5-d3bc-db422d19c399NDC 0591-4385, 43598-671Application NDA210064, ANDA211160
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose | 43598-671-11 | Dr. Reddy's LaboratoriesIndia | 12 February 2026 |
| 1 injection, powder, lyophilized, for solution in 1 carton | 0591-4385-79 | Actavis Pharma | 19 September 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Fosaprepitant
Clinical summary
Fosaprepitant is a substance P/neurokinin-1 receptor antagonist. It is available as powder for injection and injection for intravenous use. MedsAcross supplies Fosaprepitant for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FosaprepitantFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EMEND prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Ivemend: European public assessment report (EPAR) · European Medicines Agency
Need Fosaprepitant 150 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.